secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dogwood Therapeutics, Inc. (DWTX)
CIK:        0001818844
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001558370-24-009066
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Virios Therapeutics granted Nasdaq exception until Oct 28, 2024 to regain $1.00 bid price compliance
--------------------------------------------------------------------------------

- Nasdaq Hearing Panel grants exception until October 28, 2024 to meet minimum $1.00 bid price rule.
- If not compliant by October 11, 2024, Company must pursue a reverse stock split by the deadline.
- Failure to regain compliance by October 28, 2024 will result in delisting from Nasdaq Capital Market.
- Initial deficiency notice was received November 7, 2023; prior 180-day cure period expired April 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024009066/0001558370-24-009066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818844/000155837024009066/viri-20240611x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-009066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer